Wird geladen...
A novel vitamin K derived anticoagulant tolerant to genetic variations of vitamin K epoxide reductase
BACKGROUND: Vitamin K antagonists (VKAs), such as warfarin, have remained the cornerstone of oral anticoagulation therapy in the prevention and treatment of thromboembolism for over half a century. They function by impairing the biosynthesis of vitamin K-dependent (VKD) clotting factors through the...
Gespeichert in:
| Veröffentlicht in: | J Thromb Haemost |
|---|---|
| Hauptverfasser: | , , , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
2021
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7925372/ https://ncbi.nlm.nih.gov/pubmed/33314621 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jth.15209 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|